Johns Hopkins spinout Sonavex received clearance from the U.S. Food and Drug Administration (FDA) for a system that delivers data on blood flow following surgery, said CEO David Narrow.

EchoSure received 510(k) regulatory clearance, which is required to market medical devices in the U.S. Narrow called it a “critical milestone” for the Canton-based medical device startup, on March 8.

“The Sonavex team worked tirelessly for more than five years to create a solution that enables surgeons and nurses to easily collect vital information in real-time so they can provide the best results for their patients,” Narrow said.

READ FULL ARTICLE HERE